CASI Pharmaceuticals, Inc (DE) Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q4 2022.
  • CASI Pharmaceuticals, Inc (DE) Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2022 was $1.4M, a 84.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $1.4M -$7.71M -84.6% Dec 31, 2022 20-F 2023-04-26
Q3 2022 $7.67M -$1.83M -19.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $8.46M -$1.34M -13.6% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $8.81M +$486K +5.84% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $9.11M +$411K +4.73% Dec 31, 2021 20-F 2023-04-26
Q3 2021 $9.5M +$484K +5.37% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $9.8M +$1.83M +23% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $8.32M +$68K +0.82% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $8.7M -$12K -0.14% Dec 31, 2020 10-K 2022-03-28
Q3 2020 $9.02M +$6.65M +282% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $7.96M +$5.25M +193% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $8.26M +$5.22M +172% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $8.71M +$8.71M Dec 31, 2019 10-K 2021-03-30
Q3 2019 $2.36M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.72M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $3.03M Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.